Results 1 to 10 of about 2,702,025 (305)

IL-6 and Type 2 Diabetes

مجلة كلية الطب, 2010
Background: Interleukin -6 (IL-6) as the key mediator of the acute phase reaction is of interest .elevated protein concentrations of IL-6 in the blood have been shown in patients with type 2 diabetes. This study aimed to investigate the association of IL-
Maha F. Almelan
doaj   +1 more source

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [PDF]

, 2016
Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. Methods In this double-blind trial, we randomly assigned patients with type 2 diabetes
Bergenstal, RM, Brown-Frandsen, K, Buse, JB, Daniels, GH, Kristensen, P, LEADER Steering Committee on behalf of the LEADER Trial Investigators, Mann, JF, Marso, SP, Nauck, MA, Nissen, SE, Pocock, S, Poulter, NR, Ravn, LS, Steinberg, WM, Stockner, M, Zinman, B   +15 more
core   +1 more source

Recommendations for diabetes type 2

Revista de la Sociedad Argentina de Diabetes, 2016
La diabetes es una enfermedad crónica y compleja que requiere de atención médica continua, con intervenciones que van más allá del mero control de la glucemia.
María Cristina Faingold
doaj   +1 more source

Type 2 Diabetes in Youth

Global Pediatric Health, 2020
The incidence of type 2 diabetes in children and adolescents in the United States rose at an annual rate of 4.8% between 2002-2003 and 2014-2015. Type 2 diabetes progresses more aggressively to complications than type 1 diabetes.
Goutham Rao MD, Elizabeth T. Jensen PhD
doaj   +1 more source

Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population [PDF]

, 2008
Background Recent studies have implicated variants of the transcription factor 7-like 2 (TCF7L2) gene in genetic susceptibility to type 2 diabetes mellitus in several different populations. The aim of this study was to determine whether variants of this
A Helgason, Abigail C Britten, AH Barnett, Anthony H Barnett, C Zhang, CM Damcott, GR Chandak, J Paul O'Hare, J Wang, JC Barrett, JC Florez, JC Florez, JV van Vliet-Ostaptchouk, LJ Scott, M Ann Kelly, R Saxena, R Zhang, RJ Loos, S Cauchi, S Cauchi, S Mayans, SE Humphries, SF Grant, Simon D Rees, Srikanth Bellary, Sudhesh Kumar, The International HapMap Consortium, U Smith, WHO Consultation   +28 more
core   +6 more sources

Type 2 diabetes mellitus and gout

Научно-практическая ревматология, 2021
Gout is the most common inflammatory arthritis in adults and has continued to increase in prevalence over the past decades. Gout is characterized by hyperuricemia with the obligatory crystallization of urates and an associated inflammatory reaction, as ...
O. V. Zhelyabina, M. S. Eliseev
doaj   +1 more source

The association between neighbourhood greenspace and type 2 diabetes in a large cross-sectional study [PDF]

, 2014
Objective: To investigate the relationship between neighbourhood greenspace and type 2 diabetes. Design: Cross-sectional. Setting: 3 diabetes screening studies conducted in Leicestershire, UK in 2004–2011.
Astell-Burt, Bibby, Boruff, Coombes, D'Agostino, Dalton, ESRI, Giles-Corti, Gill, Gillies, Gray, Gray, Groenewegen, Hurvitz, Huynh, International Diabetes Federation, Kaprio, Lachowycz, Lachowycz, Lackey, Leslie, Maas, McCormack, Merchant, Mytton, Okura, Onat, OS Code Point 2004–2013, Poulsen, Sallis, Schulze, Shephard, Sigal, Sluijs, Stokols, Webb, Whitlock, Wilson, Yates   +38 more
core   +1 more source

β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. [PDF]

, 2010
ObjectiveThe islet in type 2 diabetes is characterized by β-cell apoptosis, β-cell endoplasmic reticulum stress, and islet amyloid deposits derived from islet amyloid polypeptide (IAPP).
Butler, Alexandra E, Butler, Peter C, Costes, Safia, Daval, Marie, Gurlo, Tatyana, Huang, Chang-jiang, Matveyenko, Aleksey V, Rizza, Robert A   +7 more
core   +2 more sources

Cohort profile: the ‘Biomarkers of heterogeneity in type 1 diabetes’ study—a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands

BMJ Open
Purpose The ‘Biomarkers of heterogeneity in type 1 diabetes’ study cohort was set up to identify genetic, physiological and psychosocial factors explaining the observed heterogeneity in disease progression and the development of complications in people ...
, Erwin Birnie, Giesje Nefs, Bruce H R Wolffenbuttel, Melanie M van der Klauw, Peter R van Dijk, Klaas Hoogenberg, Henk J Veeze, Henk-Jan Aanstoot, Bruce HR Wolffenbuttel, Charlotte E Vollenbrock, Pim Dekker, Lianne S M Boesten, Martine M C de Vries-Velraeds, Adriaan Kooy, Dick Mul, Sanjoy Dutta, Rita D M Varkevisser, Michael P Brugts, Petronella H L M Duijvestijn, Christine Fransman, Rob K Gonera, Esther Latres, Sandra Loves, Theo Sas, Marleen J Vosjan-Noeverman, Rita DM Varkevisser, Lianne SM Boesten, Peter R van Dijk, Petronella HLM Duijvestijn, Martine MC de Vries-Velraeds, Melanie M van der Klauw   +31 more
doaj   +1 more source

Reversal of Type 2 Diabetes Mellitus

RUHS Journal of Health Sciences, 2023
NA
Sudhir Bhandari
doaj   +1 more source